Fan ZX, Liu RX, Liu GZ. Development and refinement of diagnostic and therapeutic strategies for managing patients with cardiogenic stroke: An arduous journey. World J Clin Cases 2023; 11(4): 719-724 [PMID: 36818629 DOI: 10.12998/wjcc.v11.i4.719]
Corresponding Author of This Article
Guang-Zhi Liu, MD, Chief Doctor, Professor, Department of Neurology, Beijing Anzhen Hospital, No. 2 Anzhen Road, Chaoyang District, Beijing 100029, China. guangzhi2002@hotmail.com
Research Domain of This Article
Neurosciences
Article-Type of This Article
Minireviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Feb 6, 2023; 11(4): 719-724 Published online Feb 6, 2023. doi: 10.12998/wjcc.v11.i4.719
Development and refinement of diagnostic and therapeutic strategies for managing patients with cardiogenic stroke: An arduous journey
Ze-Xin Fan, Ri-Xia Liu, Guang-Zhi Liu
Ze-Xin Fan, Ri-Xia Liu, Guang-Zhi Liu, Department of Neurology, Beijing Anzhen Hospital, Beijing 100029, China
Author contributions: Liu GZ conceived the outline and performed the majority of the writing; Fan ZX and Liu RX performed part of writing and prepared the figures and tables.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Guang-Zhi Liu, MD, Chief Doctor, Professor, Department of Neurology, Beijing Anzhen Hospital, No. 2 Anzhen Road, Chaoyang District, Beijing 100029, China. guangzhi2002@hotmail.com
Received: October 6, 2022 Peer-review started: October 6, 2022 First decision: December 13, 2022 Revised: December 22, 2022 Accepted: January 12, 2023 Article in press: January 12, 2023 Published online: February 6, 2023 Processing time: 123 Days and 1.9 Hours
Abstract
Cardioembolic stroke, referred to as cardiogenic stroke, is a clinical syndrome in which emboli from the heart pass through the circulatory system and cause cerebral artery embolism and corresponding brain dysfunction. Compared to other subtypes of ischemic stroke, cardiogenic stroke presents with more etiologies, greater severity, worse prognosis, and a higher recurrence rate. In this minireview, we provide new insights into the etiological classification, diagnostic methods, and interventions of cardiogenic stroke.
Core Tip: There are many reviews focused on the diagnosis and treatment strategies of cardiogenic stroke. However, in clinical practice, there are still many problems such as non-standard diagnosis and large differences in treatment measures. In this minireview, we introduce the latest Chinese expert consensus on cardiogenic stroke-based diagnostic criteria and provide some new insights into the etiological classification and interventions of cardiogenic stroke.
